Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.98 |
| ▸ | MEN1 | O00255 | 3/20 | 0.98 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.98 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.98 |
| ▸ | LMNA | P02545 | 1/20 | 0.98 |
| ▸ | PGR | P06401 | 1/20 | 0.98 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.98 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.98 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.98 |
| ▸ | HPGD | P15428 | 1/20 | 0.98 |
| ▸ | CNR1 | P21554 | 1/20 | 0.98 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.98 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.98 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.98 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.98 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.98 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.98 |
| ▸ | BLM | P54132 | 1/20 | 0.98 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.98 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30382974 | 1.00 | MAPT (0.98) | MAPTMEN1KMT2ANR1I2LMNA | |
| SCHEMBL9364195 | 1.00 | MAPT (0.98) | MAPTMEN1KMT2ANR1I2LMNA | |
| Sofalcone SCHEMBL40766 | 0.99 | MAPT (1.00) | MAPTMEN1KMT2ANR1I2LMNA | |
| Sofalcone SCHEMBL24786 | 0.99 | MAPT (1.00) | MAPTMEN1KMT2ANR1I2LMNA | |
| Sofalcone SCHEMBL30383975 | 0.99 | MAPT (1.00) | MAPTMEN1KMT2ANR1I2LMNA | |
| Sofalcone SCHEMBL25214686 | 0.99 | MAPT (1.00) | MAPTMEN1KMT2ANR1I2LMNA | |
| Sofalcone SCHEMBL29363342 | 0.99 | MAPT (1.00) | MAPTMEN1KMT2ANR1I2LMNA | |
| Sofalcone SCHEMBL7842101 | 0.98 | MAPT (0.98) | MAPTMEN1KMT2ANR1I2LMNA | |
| Sofalcone SCHEMBL10888696 | 0.95 | MAPT (0.92) | MAPTMEN1KMT2ANR1I2LMNA | |
| SCHEMBL9368121 | 0.93 | MAPT (0.89) | MAPTMEN1KMT2ANR1I2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE33109-E | ANTIULCER, ANTIINFLAMMATORY | BIOREX LABORATORIES LIMITED (GB) | 1989-11-07 | — | — | US | claimed |
| US-4656305-A | ANTIINFLAMMATORY AND ANTIULCER AGENTS; ANTIALLERGENS; ANALGESICS | BIOREX LABORATORIES, LIMITED (GB) | 1987-04-07 | — | — | US | claimed |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| WO-2024233598-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2024-11-14 | — | — | WO | disclosed |
| EP-4429763-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | Yewsavin, Inc. (US) | 2024-09-18 | — | — | EP | disclosed |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
| EP-0412803-B1 | Chalcone derivatives | TAISHO PHARMACEUTICAL CO LTD (JP) | 1994-03-23 | — | — | EP | disclosed |
| US-5089654-A | Antiulcer agents | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1992-02-18 | — | — | US | disclosed |
| EP-0412803-A1 | Chalcone derivatives | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1991-02-13 | — | — | EP | disclosed |
| US-RE33109-E | ANTIULCER, ANTIINFLAMMATORY | BIOREX LABORATORIES LIMITED (GB) | 1989-11-07 | — | — | US | disclosed |
| US-4656305-A | ANTIINFLAMMATORY AND ANTIULCER AGENTS; ANTIALLERGENS; ANALGESICS | BIOREX LABORATORIES, LIMITED (GB) | 1987-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | MAPT 3297/4885MEN1 3367/4885KMT2A 2792/4885 |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | SERPINC1, SERPINE1, SERPINH1 | MAPT 3512/4885MEN1 2457/4885KMT2A 3188/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | MAPT 3512/4885MEN1 2457/4885KMT2A 3188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.